Month: August 2016
-
Sleeping Sickness Treatment Found in Cancer Drug
An experimental drug designed to treat solid tumor cancers was shown in lab tests to rid mice of human African trypanosomiasis, also known as sleeping sickness.
-
Small Molecule Drug Discovery Patent Issued
A company developing small-molecule treatments for biological targets considered difficult to address is receiving a patent for its core drug identification technology.
-
Non-Addictive Pain Medication Shown Working in Animals
An experimental medication was shown in tests with monkeys to relieve pain for more than a day without the addictive properties or adverse physical effects of opioids.
-
Synthetic Biotech Research Microbe Developed
An artificial form of marine bacteria is being created to speed experiments in biotechnology labs on cloning and design of new therapeutic proteins.
-
Heart Research Built Into Personalized Activity Tracker
An activity tracking device introduced earlier this year uses data from a major population health study to write its algorithms measuring exercise achievement to prevent heart disease.
-
Spacecraft Returns with Space Station Research Samples
A SpaceX Dragon spacecraft returned today with samples from several biomedical research studies conducted by astronauts on the International Space Station.
-
Small Business Award Funding Epilepsy Drug Research
A federal grant is funding a project by Neuroene Therapeutics, a start-up enterprise in South Carolina to develop a new class of drugs to treat epilepsy.
-
Inexpensive Hydrogen Storage Devised for Solar Energy
An engineering team in Switzerland designed a system for producing hydrogen from solar power with abundant available materials, providing an inexpensive and feasible energy storage method.
-
Lower-Risk Blood Thinning Drugs Designed
Researchers from academic and industry labs designed anti-coagulation treatments for people in danger of blood clots, but less likely to cause excessive bleeding than current drugs.
-
Patent Set for Heart Tissue Regeneration Drug
A drug developed by MDI Biological Laboratory that stimulates growth of heart tissue to fix damage from heart attacks is scheduled to receive a U.S. patent.